The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Komarov S.D.

Moscow Research and Practical Centre on Addictions of the Moscow Department of Healthcare

Vdovin A.S.

Moscow Research and Practical Centre on Addictions of the Moscow Department of Healthcare

Vinnikova M.A.

Sechenov First Moscow State Medical University (Sechenov University);
Moscow Research and Practical Centre on Addictions of the Moscow Department of Healthcare

Severtsev V.V.

Sechenov First Moscow State Medical University (Sechenov University);
Scientific and Practical Toxicology Center Federal Medical and Biological Agency of Russia

Fluvoxamine in the treatment of depressive disorders in alcohol dependence: results of randomized open-label comparative study

Authors:

Komarov S.D., Vdovin A.S., Vinnikova M.A., Severtsev V.V.

More about the authors

Views: 5793

Downloaded: 215


To cite this article:

Komarov SD, Vdovin AS, Vinnikova MA, Severtsev VV, Komarov SD, Vdovin AS. Fluvoxamine in the treatment of depressive disorders in alcohol dependence: results of randomized open-label comparative study. S.S. Korsakov Journal of Neurology and Psychiatry. 2021;121(12):57‑62. (In Russ.)
https://doi.org/10.17116/jnevro202112112157

Recommended articles:
Targeting NMDAR/AMPAR: a promising pharmacotherapeutic approach for depressive diso­rders. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(5):22-30
Asthenia in young patients and possibilities for its correction. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(5):133-137
Sleep diso­rders and onco­logical diseases. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(5-2):125-131
Reco­gnan (citicoline) in the correction of asthenic and anxiety-depressive diso­rders. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(6):43-47
Fluvoxamine in the treatment of anxiety-depressive spectrum diso­rders. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(6):101-109
Anti­depressants in psychiatric practice. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(6):126-132

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.